About us
Research Library
Company Pages
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Redx Pharma
Scancell
Contact us
More Company News
Arecor Therapeutics
Additional formulation agreement with Top 5 global pharma partner
14 Feb 2023
Read More
Arecor Therapeutics
AT278 data published in Diabetes Care
30 Jan 2023
Read More
Arecor Therapeutics
Business update
19 Jan 2023
Read More
Arecor Therapeutics
AT307 transfers to Hikma
12 Jan 2023
Read More
Arecor Therapeutics
Tetris Pharma launches Ogluo in Austria
04 Jan 2023
Read More
Arecor Therapeutics
Tetris Pharma agreement with Syneos Health
12 Dec 2022
Read More
Arecor Therapeutics
Second AT278 trial to commence in Type II diabetes
22 Nov 2022
Read More
Arecor Therapeutics
Insulin product patents granted in Japan and South Korea
22 Nov 2022
Read More
Arecor Therapeutics
Exclusive Specialty Hospital formulation collaboration
10 Nov 2022
Read More
Arecor Therapeutics
Tetris Pharma launches Ogluo in Germany
01 Nov 2022
Read More
1
2
3
4
Return to Arecor Therapeutics
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About us
Research Library
Company Pages
▼
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Redx Pharma
Scancell
Contact us